Related Experiment Video

Updated: Apr 8, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.9K

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

David M Fleischer, Scott Sicherer, Matthew Greenhawt

    Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
    |July 1, 2015
    PubMed

    Insights

    Early peanut introduction in infants, during complementary feeding, may offer benefits over delayed introduction. This interim guidance reflects a consensus among leading allergy and pediatric organizations worldwide.

    Area of Science:

    • Pediatric Allergy and Immunology
    • Infant Nutrition and Allergy Prevention

    Background:

    • Existing guidelines on infant feeding practices are being re-evaluated.
    • Emerging evidence suggests a shift in recommendations for early allergen introduction.

    Purpose of the Study:

    • To highlight emerging evidence on the benefits of early peanut introduction in infants.
    • To provide interim guidance on complementary feeding and allergy risk.

    Main Methods:

    • Consensus statement based on emerging scientific evidence.
    • Involves multiple international allergy and pediatric organizations.

    Main Results:

    • Emerging evidence supports earlier, rather than delayed, introduction of peanut.
    • This approach is recommended during the complementary food introduction period for infants.

    Conclusions:

    • Interim guidance suggests potential benefits of early peanut introduction for allergy prevention.
    • Formal guidelines are forthcoming from major research groups and organizations.

    Keywords:
    Allergy preventioncomplementary feedingpeanut allergy

    More Related Videos

    Antigenic Liposomes for Generation of Disease-specific Antibodies10:31

    Antigenic Liposomes for Generation of Disease-specific Antibodies

    Published on: October 25, 2018

    13.0K
    Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus10:24

    Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus

    Published on: April 19, 2024

    1.8K

    Related Concept Videos

    Allergic Drug Reactions01:27

    Allergic Drug Reactions

    Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
    1.6K
    Allergic Reactions: Anaphylaxis01:30

    Allergic Reactions: Anaphylaxis

    Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
    186
    Allergic Reactions02:06

    Allergic Reactions

    Overview
    33.9K
    Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

    Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

    Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
    217
    Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

    Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

    Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
    Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
    2.4K
    Asthma: Pathogenesis and Management01:20

    Asthma: Pathogenesis and Management

    Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
    Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
    1.7K